Uploaded October 2026 | Updated November 2026, 3 days ago
Join our livestreamed expert exchange on modern hyperphosphatemia management in dialysis-dependent chronic kidney disease (CKD). Managing serum phosphorus remains challenging due to heavy pill burdens and side effects. Our experts will explore emerging clinical evidence on novel nonbinder phosphate-lowering agents vs conventional binders.
Panelists will share practical, real-world insights to address clinical challenges, optimize patient care, and enhance quality of life. Gain confidence in applying the latest recommended strategies and tailoring individualized treatments that reduce overall patient burden.
Faculty: Matthew Weir, MD
Faculty: Leah D. Foster-Smith, MSN, APRN, FNP-BC, CNN-NP, FNKF, FANNA, FAANP
img.medscapestatic.com/vim/live/professional_assets/medscape/prof_documents/Activity%20and%20Disclosures%20452819-23%20re-edit.pdf
Supported by an independent educational grant from Ardelyx.
Join our livestreamed expert exchange on modern hyperphosphatemia management in dialysis-dependent chronic kidney disease (CKD). Managing serum phosphorus remains challenging due to heavy pill burdens and side effects. Our experts will explore emerging clinical evidence on novel nonbinder phosphate-lowering agents vs conventional binders.
Panelists will share practical, real-world insights to address clinical challenges, optimize patient care, and enhance quality of life. Gain confidence in applying the latest recommended strategies and tailoring individualized treatments that reduce overall patient burden.
Faculty: Matthew Weir, MD
Faculty: Leah D. Foster-Smith, MSN, APRN, FNP-BC, CNN-NP, FNKF, FANNA, FAANP
img.medscapestatic.com/vim/live/professional_assets/medscape/prof_documents/Activity%20and%20Disclosures%20452819-23%20re-edit.pdf
Supported by an independent educational grant from Ardelyx.










